Cases
Moline v. BioVentrix, Inc.
- Corporate Governance / Derivative Action
Overview
Overview
Status: | Status: Pending |
Court: | Court: Delaware Chancery Court |
Case Number: | Case Number: 2023-0883-PAF |
Lead Attorneys: | Lead Attorneys: Derrick Farrell |
Background: On August 28, 2023, Bleichmar Fonti & Auld LLP filed Gary Moline’s Verified Class Action complaint against BioVentrix, Inc. (“BioVentrix”), its then Directors, and two entities (Taglich Brothers Inc., and Richmond Brothers, Inc.) alleged to be controllers of BioVentrix. The complaint alleges that the Defendants breached their fiduciary duties by orchestrating the February 10, 2023, 65,500-1 reverse stock split that completely cashed out any holders of BioVentrix stock who owned fewer than 65,500 shares for $0.01 per share. Applying that valuation to the whole enterprise, the entire company would be worth $286.27. This is inconsistent with the fact that shortly after the reverse split, BioVentrix raised $48.5 million in equity financing. The plaintiffs seek damages in an amount to be determined at trial.
BFA’s Role: BFA is the sole counsel representing Plaintiff Gary Moline.
Status: The Case is currently proceeding through discovery following the denial of the motion to dismiss.
BFA’s Role: BFA is the sole counsel representing Plaintiff Gary Moline.
Status: The Case is currently proceeding through discovery following the denial of the motion to dismiss.